Elanco

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Elanco and other ETFs, options, and stocks.

About ELAN

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. 

CEO
Jeffrey N. Simmons
CEOJeffrey N. Simmons
Employees
9,450
Employees9,450
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1954
Founded1954
Employees
9,450
Employees9,450

ELAN Key Statistics

Market cap
11.07B
Market cap11.07B
Price-Earnings ratio
305.21
Price-Earnings ratio305.21
Dividend yield
Dividend yield
Average volume
5.15M
Average volume5.15M
High today
$22.29
High today$22.29
Low today
$21.44
Low today$21.44
Open price
$21.52
Open price$21.52
Volume
8.22M
Volume8.22M
52 Week high
$23.09
52 Week high$23.09
52 Week low
$8.02
52 Week low$8.02

Stock Snapshot

As of today, Elanco(ELAN) shares are valued at $22.25. The company's market cap stands at 11.07B, with a P/E ratio of 305.21.

As of 2025-11-23, Elanco(ELAN) stock has fluctuated between $21.44 and $22.29. The current price stands at $22.25, placing the stock +3.8% above today's low and -0.2% off the high.

The Elanco(ELAN)'s current trading volume is 8.22M, compared to an average daily volume of 5.15M.

During the past year, Elanco(ELAN) stock moved between $8.02 at its lowest and $23.09 at its peak.

During the past year, Elanco(ELAN) stock moved between $8.02 at its lowest and $23.09 at its peak.

ELAN News

Benzinga 2d
Elanco Animal Health Stock Is Undervalued: Analyst

As the pet care industry experiences rapid growth, pharmaceutical companies are increasingly focusing on developing innovative treatments for companion animals....

Elanco Animal Health Stock Is Undervalued: Analyst
TipRanks 3d
KeyBanc starts Elanco at Overweight on revenue growth efforts

KeyBanc initiated coverage of Elanco (ELAN) with an Overweight rating and $27 price target The firm expects success of the company’s recent product launches to...

TipRanks 4d
Elanco upgraded to Buy from Hold at Argus

Argus analyst Jasper Hellweg upgraded Elanco (ELAN) to Buy from Hold with a $25 price target Published first on TheFly – the ultimate source for real-time, mar...

Analyst ratings

76%

of 17 ratings
Buy
76.5%
Hold
17.6%
Sell
5.9%

People also own

Based on the portfolios of people who own ELAN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.